Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Click here to browse AJSM online!

Sign In to gain access to subscriptions and/or personal tools.
Clinical Pediatrics
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Perkin, R. M.
Right arrow Articles by Marks, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perkin, R. M.
Right arrow Articles by Marks, J. F.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Low-Dose Continuous Intravenous Insulin Infusion in Childhood Diabetic Ketoacidosis

Ronald M. Perkin, M.D.

Department of Pediatrics, University of Texas Health Science Center at Dallas, Dallas, Texas.

James F. Marks, M.D.

Department of Pediatrics, University of Texas Health Science Center at Dallas, Dallas, Texas.

We studied 58 children with diabetic ketoacidosis using a random, prospec tive protocol, with insulin administered either as a low-dose continuous in fusion or as high-dose intermittent subcutaneous injections. There were no statistically significant differences between admission pH and glucose deter minations or the time to metabolic correction. The incidence of hypoglycemia and hypokalemia was higher in patients receiving subcutaneous insulin. In sulin levels in the low-dose patients were 85-160 µU/ml. The insulin required to achieve metabolic recovery was 1.6 U/kg in the low-dose group and 4.5 U/kg in the high-dose group (p < 0.01). Glucose administered at a rate of 3 to 4 g per unit of insulin infused in the low-dose group maintained a serum glucose of 150 to 250 mg/dl. Our studies suggest that low-dose intravenous insulin therapy is safe, as effective as high-dose intermittent subcutaneous injections and avoids the risks of hypoglycemia and hypokalemia. Meticulous attention to individual patient care, however, must remain the most important single variable.

Clinical Pediatrics, Vol. 18, No. 9, 540-548 (1979)
DOI: 10.1177/000992287901800904


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?